ORX750, an Oral Orexin Receptor 2 Agonist, in Participants with Narcolepsy Type 1: Preliminary Results from a Phase 2a Trial Parallel-Design Analysis

Plazzi G, Dauvilliers Y, Mignot E, Sterkel A, Salek Y, Kozauer S, Leary EB, Yong L, Accardi MA, Kanes S. ORX750, an Oral Orexin Receptor 2 Agonist, in Participants with Narcolepsy Type 1: Preliminary Results from a Phase 2a Trial Parallel-Design Analysis. Sleep 49(suppl_1), In Press.